Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference30 articles.
1. Chang S, Parker SL, Pham T, et al.: Inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute, 1975-1992. Cancer 1998, 82:2366–2372.
2. Hortobagyi GN, Singletary SE, Strom EA: Treatment of locally advanced and inflammatory breast cancer. In Diseases of the Breast, edn 2. Edited by Harris JR, Lippman ME, Morrow M, Osborne CK. Philadelphia: Lippincott Williams & Wilkins; 2000:645–660. An excellent discussion of the development of current treatment approaches.
3. Fisher B, Bryant J, Wolmark N, et al.: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998, 16:2672–2685. A pivotal study of neoadjuvant versus adjuvant chemotherapy.
4. Kuerer HM, Newman LA, Smith TL, et al.: Clinical course of breast cancer patients with complete pathologic response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 1999, 17:460–469. Analysis of long-term outcome for patients who achieve a pCR.
5. Kuerer HM, Sahin AA, Hunt KK, et al.: Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 1999, 230:72–78.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献